Quick Answer
NP Life Sciences Health Industry Group Inc. reported Stockholders Equity of $16.4 thousand for fiscal year 2023.
NP Life Sciences Health Industry Group Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2023 | $16.4K | -15.2% |
| 2022 | $19.3K | -49.4% |
| 2021 | $38.2K | -63.2% |
| 2020 | $103.8K | -55.8% |
| 2019 | $234.9K | +1235.7% |
| 2018 | -$20.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $31.7K | +1067.6% | -52.7% |
| June 30, 2023 | $67.1K | +722.6% | +226.8% |
| March 31, 2023 | $20.5K | +190.1% | +6.3% |
| December 31, 2022 | $19.3K | -49.4% | +610.7% |
| September 30, 2022 | $2.7K | -54.0% | -66.7% |
| June 30, 2022 | $8.2K | -69.6% | +15.2% |
| March 31, 2022 | $7.1K | -91.1% | -81.5% |
| December 31, 2021 | $38.2K | -63.2% | +546.7% |
- NP Life Sciences Health Industry Group Inc. showed a decrease of -15.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2023 period, NP Life Sciences Health Industry Group Inc.’s stockholders equity has grown by 179.2% (from -$20.7 thousand to $16.4 thousand).
- The most recent figure is from NP Life Sciences Health Industry Group Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 16, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: